Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil

Cadernos de saúde pública
Indianara Maria GrandoGilmara Lima Nascimento

Abstract

The objective of this study was to analyze the impact of vaccination against Streptococcus pneumoniae on the morbidity and mortality from pneumococcal meningitis in children ≤ 2 years in Brazil, from 2007 to 2012. This is a descriptive study and ecological analysis using data from the Information System on Notifiable Diseases. Pre-vaccination (2007-2009) and post-vaccination (2011-2012) periods were defined to compare incidence rates and mortality. A total of 1,311 cases and 430 deaths were reported during the study period. Incidence decreased from 3.70/100,000 in 2007 to 1.84/100,000 in 2012, and mortality decreased from 1.30/100,000 to 0.40/100,000, or 50% and 69% respectively, with the greatest impact in the 6-11 month age group. This decrease in Pneumococcal meningitis morbidity and mortality rates two years after introduction of the 10-valent pneumococcal conjugate vaccine suggests its effectiveness.

References

Feb 12, 1998·The New England Journal of Medicine·A SchuchatB A Perkins
May 2, 2003·The New England Journal of Medicine·Cynthia G WhitneyUNKNOWN Active Bacterial Core Surveillance of the Emerging Infections Program Network
Aug 9, 2003·Journal of Clinical Microbiology·Ana Lucia Sampaio Sgambatti de AndradeJose Luis Di Fabio
Oct 3, 2003·The New England Journal of Medicine·Keith P KlugmanUNKNOWN Vaccine Trialists Group
Oct 29, 2004·The New England Journal of Medicine·Morton N Swartz
Jan 25, 2005·The Pediatric Infectious Disease Journal·Katherine HsuUNKNOWN Massachusetts Department of Public Health Epidemiologists
Nov 9, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·James D KellnerDavid Scheifele
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Katherine A PoehlingWilliam Schaffner
May 13, 2006·MMWR. Morbidity and Mortality Weekly Report·UNKNOWN Centers for Disease Control and Prevention (CDC)
Jul 13, 2007·Archives of Disease in Childhood·F DubosUNKNOWN Hospital Network for Evaluating the Management of Common Childhood Diseases
Jan 16, 2009·The New England Journal of Medicine·Heather E HsuLee H Harrison
Mar 20, 2009·Seminars in Respiratory and Critical Care Medicine·Joseph P Lynch, George G Zhanel
Sep 15, 2009·Lancet·Katherine L O'BrienUNKNOWN Hib and Pneumococcal Global Burden of Disease Study Team
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Apr 23, 2010·Emerging Infectious Diseases·Gerwin D RodenburgArie van der Ende
May 1, 2013·Emerging Infectious Diseases·Eliane Terezinha AfonsoAna Lucia Andrade

❮ Previous
Next ❯

Citations

Feb 26, 2016·Human Vaccines & Immunotherapeutics·Ana Lucia AndradeAna Luiza Bierrenbach
Apr 15, 2017·Expert Review of Vaccines·Robert CohenCorinne Levy
Feb 22, 2017·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·María Noemí Carnalla-BarajasUNKNOWN Grupo SIREVA-Mexico
May 22, 2020·Frontiers in Pediatrics·Alexandre M PimentelCristiana M Nascimento-Carvalho
Apr 25, 2016·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Sandra Rodrigues da SilvaAltacílio Aparecido Nunes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.